• With Johnson and Johnson, Harvard Spinoff Emulate Unveils New Organs-on-Chips

    Bio-IT World | Emulate, a for-profit spinoff of Harvard's Wyss Institute, is announcing that a partnership with Johnson & Johnson has produced a new Thrombosis-on-Chip model for testing drug candidates and studying the biology of blood clotting, in a preview of the company's model for creating and disseminating next-generation organs-on-chips.

    Jun 18, 2015

  • Juno's T-Cell Immunotherapy Cure for Cancer

    MIT Technology Review | Supercharge your immune cells to defeat cancer? Juno Therapeutics believes its treatments can do exactly that.

    Jun 18, 2015

  • Googles data centers grow so fast it has to build its own networks

    Computerworld | Google has been building its own software-defined data-center networks for 10 years because traditional gear can't handle the scale of its warehouse-sized computers.

    Jun 18, 2015

  • Tute Genomics Announces Investment Round from Intermountain, Tencent

    Bio-IT World News Brief | Tute Genomics today announced the closing of its Series A1 round of venture capital funding. The company raised over $3.9 million from a strategic group of investors, including Intermountain Healthcare, Healthbox, and China-based Tencent.

    Jun 16, 2015

  • Whole Genome Assembly with Nanopore Data

    Bio-IT World News Brief | Nature Methods has published a paper by researchers at the University of Birmingham and University of Toronto, demonstrating a complete de novo assembly of an E. coli genome using only data from an Oxford Nanopore MinION Sequencer.

    Jun 16, 2015

  • FDA taps PatientsLikeMe to test the waters of social media adverse event reporting

    mobihealthnews | PatientsLikeMe has announced a research partnership with the FDA: The agency will assess the platform's feasibility as a way to generate adverse event reports, which the FDA uses to regulate drugs after their release into the market.

    Jun 16, 2015

  • Matthew Trunnell Joins Fred Hutchinson Cancer Research Center

    Xconomy | Trunnell leaves the Broad to serve as the chief information officer as the biomedical institution moves into an era of deep genomic sequencing.

    Jun 16, 2015

  • Outpouring of Commentary on CRISPR Germline Editing

    Bio-IT World News Brief | A supplementary document to a recent Nature Biotechnology article on the use of CRISPR-Cas9 genome editing in the human germline offers complete Q&A's with over 20 experts in the field, taking on pressing questions about how and whether this technology can be regulated.

    Jun 10, 2015

  • ClinGen and Lessons for the Precision Medicine Initiative

    Bio-IT World | Heidi Rehm has been involved in ClinGen since its inception and recently published a report on the project in the New England Journal of Medicine. Rehm’s experience with ClinGen will make hers an important voice as the infrastructure needs for a Precision Medicine Initiative are better defined.

    Jun 10, 2015

  • BGI's Industrial Scale Sequencer Challenges Illumina's HiSeq Line

    Bio-IT World | BGI, the Shenzhen-based global genomics corporation, has revealed its first DNA sequencing instrument for worldwide markets, Revolocity: an ultra-high-throughput, fully automated system based on technology developed by BGI's subsidiary Complete Genomics.

    Jun 8, 2015

  • Kickstarter Launched for Social Reader

    Bio-IT World | David Mittelman and his colleagues at N of Everyone today launch a Kickstarter campaign to fund Reader, a mobile and social reading platform to promote conversation and collaboration within science. 

    Jun 8, 2015

  • The Human Virome's Permanent Mark

    Bio-IT World | The human body is host to an astonishing array of viruses, but efforts to study this secretive population have hit technological limitations. At Brigham & Women's Hospital in Boston, a new blood test is letting researchers look at patients' whole histories of viral infection, using their antibodies as a permanent record.

    Jun 5, 2015